Biology and Biotechnologies for Health Laboratory - UMR_S 1292 CEA/Inserm/UGA - Sur le même thème https://biosante-lab.fr/en/Pages/News/2023/21_Laurent-Guyon.aspx en-US https://biosante-lab.fr/en/SiteAssets/min_logo_Biosante.png Biology and Biotechnologies for Health Laboratory - UMR_S 1292 CEA/Inserm/UGA - Sur le même thème https://biosante-lab.fr/en Tumoroids for personalized anti-tumor treatments https://biosante-lab.fr/en/Pages/News/2023/23_Odile-Filhol-Cochet.aspx highlight / actuality personalized medicine;IMAC;tumoroid;kidney cancer; Mon, 13 Nov 2023 11:00:00 GMT Using genetics to identify kidney cancers most at risk https://biosante-lab.fr/en/Pages/News/2023/21_Laurent-Guyon.aspx highlight / actuality COL7A1;IMAC;biomarker;kidney cancer; Mon, 19 Jun 2023 10:00:00 GMT Kidney cancer: Two targets for one therapy https://biosante-lab.fr/en/Pages/News/2021/12_Odile-Filhol-Cochet.aspx highlight / actuality CMBA;CK2;IMAC;chemogenomics;screening;pharmacology;Patent;kidney cancer;GenChem;Cancer;therapy; Tue, 09 Mar 2021 11:00:00 GMT Clear-cell renal carcinoma: Towards a personalized medicine https://biosante-lab.fr/en/Pages/News/2018/Odile-Filhol.aspx researchers highlight / actuality IMAC;kinase;Cancer;renal cancer;kidney cancer;personalized medicine; Thu, 13 Sep 2018 10:00:00 GMT Identification of new therapeutic targets for kidney cancers https://biosante-lab.fr/en/Pages/News/2016/Odile-Filhol.aspx researchers ; general public highlight / actuality Cancer;CMBA;IMAC;3D culture;screening;Patent;pharmacology;spheroids;kidney cancer;inhibitor;CK2; Mon, 25 Jan 2016 11:00:00 GMT